Velocity’s research site in Medford was founded in 1997 as the Clinical Research Institute of Southern Oregon, and acquired by Velocity in 2017. As an independent research facility, our Medford site has long been a leading respiratory clinical research center, with a core focus on Allergy, Asthma and COPD clinical studies. The site is often one of the top enrolling sites nationally for these respiratory indications, and also has extensive expertise in atopic dermatitis and vaccine studies.
Located just 10 minutes from the Medford airport, the site is easily accessible and has free parking. With a population of 216,000 in Metropolitan Medford, another 300,000 residents in the surrounding counties, and a robust database of potential study participants, our Medford site is capable of recruiting thousands to our trials. With more than 8,500 square-feet of dedicated research space, our staff can efficiently and effectively conduct multiple concurrent studies. All trials are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Velocity Medford team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.
